Gennex Laboratories [GENNEX] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Gennex Laboratories

Divi's Laboratories
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Gennex Laboratories wins in 5 metrics, Divi's Laboratories wins in 14 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Gennex Laboratories | Divi's Laboratories | Better |
---|---|---|---|
P/E Ratio (TTM) | 16.41 | 67.57 | Gennex Laboratories |
Price-to-Book Ratio | 1.18 | 10.40 | Gennex Laboratories |
Debt-to-Equity Ratio | 13.93 | 0.03 | Divi's Laboratories |
PEG Ratio | 2.80 | 2.55 | Divi's Laboratories |
EV/EBITDA | 15.81 | 49.66 | Gennex Laboratories |
Profit Margin (TTM) | 11.46% | 23.89% | Divi's Laboratories |
Operating Margin (TTM) | 13.37% | 25.60% | Divi's Laboratories |
EBITDA Margin (TTM) | 13.37% | 25.60% | Divi's Laboratories |
Return on Equity | 9.31% | 14.64% | Divi's Laboratories |
Return on Assets (TTM) | 7.08% | 12.94% | Divi's Laboratories |
Free Cash Flow (TTM) | $-197.44M | $2.15B | Divi's Laboratories |
Dividend Yield | N/A | 0.91% | N/A |
1-Year Return | -41.07% | 8.12% | Divi's Laboratories |
Price-to-Sales Ratio (TTM) | 2.16 | 16.13 | Gennex Laboratories |
Enterprise Value | $2.75B | $1,522.01B | Divi's Laboratories |
EV/Revenue Ratio | 1.92 | 15.77 | Gennex Laboratories |
Gross Profit Margin (TTM) | 35.05% | 60.33% | Divi's Laboratories |
Revenue per Share (TTM) | $7 | $363 | Divi's Laboratories |
Earnings per Share (Diluted) | $0.78 | $86.82 | Divi's Laboratories |
Beta (Stock Volatility) | 0.31 | 0.18 | Divi's Laboratories |
Gennex Laboratories vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Gennex Laboratories | -0.55% | 8.38% | 11.50% | 2.32% | -9.28% | -25.32% |
Divi's Laboratories | -0.67% | 3.10% | -4.83% | -14.69% | 1.79% | -3.41% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Gennex Laboratories | -41.07% | 96.92% | 228.21% | 181.32% | 759.06% | 975.63% |
Divi's Laboratories | 8.12% | 57.02% | 83.89% | 435.51% | 1,516.65% | 7,132.15% |
News Based Sentiment: Gennex Laboratories vs Divi's Laboratories
Gennex Laboratories
News based Sentiment: MIXED
Gennex Laboratories experienced a stock price reversal and reported positive Q1 FY2026 results, but continues to face significant long-term declines and saw a large insider sell transaction. These mixed signals create a complex investment picture, making October a noteworthy but not transformative month for the company.
Divi's Laboratories
News based Sentiment: MIXED
Divi's Laboratories reported strong Q3 results, but also faces mixed analyst opinions, recent underperformance, and a shift in technical trends. The company is also taking on new debt, indicating a strategic change. These factors create a complex investment narrative.
Performance & Financial Health Analysis: Gennex Laboratories vs Divi's Laboratories
Metric | GENNEX | DIVISLAB |
---|---|---|
Market Information | ||
Market Cap | ₹3.11B | ₹1.61T |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 642,874 | 455,187 |
90 Day Avg. Volume | 571,621 | 395,686 |
Last Close | ₹12.73 | ₹5,826.50 |
52 Week Range | ₹10.84 - ₹19.00 | ₹4,955.00 - ₹7,071.50 |
% from 52W High | -33.00% | -17.61% |
All-Time High | ₹29.00 (Sep 16, 2024) | ₹7,071.50 (Jul 08, 2025) |
% from All-Time High | -56.10% | -17.61% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.21% | 0.14% |
Quarterly Earnings Growth | 0.08% | 0.27% |
Financial Health | ||
Profit Margin (TTM) | 0.11% | 0.24% |
Operating Margin (TTM) | 0.13% | 0.26% |
Return on Equity (TTM) | 0.09% | 0.15% |
Debt to Equity (MRQ) | 13.93 | 0.03 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹10.85 | ₹563.87 |
Cash per Share (MRQ) | ₹2.40 | ₹132.86 |
Operating Cash Flow (TTM) | ₹-75,467,000 | ₹19.67B |
Levered Free Cash Flow (TTM) | ₹181.23M | ₹21.91B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.91% |
Last 12-Month Dividend | ₹0.00 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Gennex Laboratories vs Divi's Laboratories
Metric | GENNEX | DIVISLAB |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 16.41 | 67.57 |
Forward P/E | N/A | 104.19 |
PEG Ratio | 2.80 | 2.55 |
Price to Sales (TTM) | 2.16 | 16.13 |
Price to Book (MRQ) | 1.18 | 10.40 |
Market Capitalization | ||
Market Capitalization | ₹3.11B | ₹1.61T |
Enterprise Value | ₹2.75B | ₹1.52T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.92 | 15.77 |
Enterprise to EBITDA | 15.81 | 49.66 |
Risk & Other Metrics | ||
Beta | 0.31 | 0.18 |
Book Value per Share (MRQ) | ₹10.85 | ₹563.87 |
Financial Statements Comparison: Gennex Laboratories vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | GENNEX | DIVISLAB |
---|---|---|
Revenue/Sales | ₹341.78M | ₹24.10B |
Cost of Goods Sold | ₹221.97M | ₹9.56B |
Gross Profit | ₹119.81M | ₹14.54B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹45.68M | ₹6.17B |
EBITDA | ₹73.49M | ₹8.48B |
Pre-Tax Income | ₹58.66M | ₹7.33B |
Income Tax | ₹8.50M | ₹1.88B |
Net Income (Profit) | ₹50.16M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | GENNEX | DIVISLAB |
---|---|---|
Cash & Equivalents | ₹545.89M | ₹4.15B |
Total Current Assets | ₹1.81B | ₹100.81B |
Total Current Liabilities | ₹445.55M | ₹14.52B |
Long-Term Debt | ₹168.93M | ₹20.00M |
Total Shareholders Equity | ₹1.95B | ₹149.69B |
Retained Earnings | ₹562.59M | ₹134.00B |
Property, Plant & Equipment | ₹88.69M | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | GENNEX | DIVISLAB |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | GENNEX | DIVISLAB |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 642,874 | 455,187 |
Average Daily Volume (90 Day) | 571,621 | 395,686 |
Shares Outstanding | 227.45M | 265.47M |
Float Shares | 132.11M | 120.77M |
% Held by Insiders | 0.31% | 0.52% |
% Held by Institutions | 0.00% | 0.29% |
Dividend Analysis & Yield Comparison: Gennex Laboratories vs Divi's Laboratories
Metric | GENNEX | DIVISLAB |
---|---|---|
Last 12-Month Dividend | ₹0.00 | ₹60.00 |
Last 12-Month Dividend Yield | N/A | 0.91% |
3-Year Avg Annual Dividend | ₹0.00 | ₹50.00 |
3-Year Avg Dividend Yield | N/A | 0.70% |
3-Year Total Dividends | ₹0.00 | ₹150.00 |
Ex-Dividend Date | N/A | Jul 25, 2025 |